AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session Across the COAST 1, COAST 2,...
AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
- Across the COAST 1, COAST 2, and SHORE phase 3 studies, amlitelima… [+16830 chars]






